Articles tagged with Multiple Sclerosis
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
A UC Irvine immunologist has received a $4.8 million grant to create new neural stem cells for treating multiple sclerosis. The cells aim to halt ongoing myelin loss and encourage the growth of new myelin to mend damaged nerves.
A substance in human mesenchymal stem cells promotes nerve restoration and myelin sheath repair in rodent models of multiple sclerosis. Hepatocyte growth factor, a key instigator, decreases inflammation and increases signaling molecules counteracting it, leading to neural cell growth and nerve rewinding.
A clinical study at the University of California, San Diego School of Medicine found that smoked cannabis reduced symptoms of multiple sclerosis, including improved spasticity and pain. However, the study also reported short-term adverse cognitive effects and increased fatigue.
A randomized controlled trial found smoked cannabis to be effective in reducing spasticity and pain in people with treatment-resistant multiple sclerosis. However, the study also showed that smoking cannabis was associated with acute cognitive impairments.
A recent OHSU study found that multiple sclerosis specialists have seen over 600 patients misdiagnosed with MS, resulting in unnecessary treatment costing $11 million per year. The study highlights the importance of clinical expertise in recognizing and correcting diagnostic errors.
A study published in Brain Pathology has found that halting the Kallikrein 6 enzyme can slow multiple sclerosis progression in mice. The researchers discovered an antibody that neutralizes the enzyme, which was shown to reduce inflammatory white blood cells and slow demyelination.
Lauren Strober, a researcher at Kessler Foundation, has been awarded a five-year grant to study factors related to employment in people with multiple sclerosis. Her goal is to develop a predictive model of unemployment that can help practitioners make informed decisions and assist individuals with MS in retaining jobs.
Early treatment with interferon beta-1a significantly reduced the likelihood of progression to clinically definite multiple sclerosis (MS) in a three-year clinical trial. Those who received the drug soon after their first signs of possible MS were less likely to be diagnosed with MS than those who switched from placebo.
A new US-based clinical trial is testing whether high-dose vitamin D supplements can reduce multiple sclerosis (MS) disease activity when added to standard therapy. The study aims to determine the effectiveness of vitamin D in reducing relapse rates and improving quality of life among participants with relapsing-remitting MS.
A Phase II clinical trial found that an oral drug called ONO-4641 reduced the number of lesions in people with relapsing-remitting multiple sclerosis. The study showed significant decreases in Gd-enhancing brain lesions, with doses of 0.05mg, 0.10mg, and 0.15mg resulting in 82%, 92%, and 77% fewer lesions compared to placebo.
A randomized controlled trial found that omega-3 fatty acid supplementation had no beneficial effects on disease activity in patients with relapsing-remitting multiple sclerosis. The study included 92 patients who received either omega-3 fatty acids or a placebo for six months, followed by interferon beta treatment for another 18 months.
The Kessler Foundation has been awarded a $383,000 five-year grant from the National Multiple Sclerosis Society to fund postdoctoral fellowships in MS rehabilitation research. The program provides advanced training for scientists working towards careers dedicated to improving the lives of people with MS.
A minimally invasive endovascular treatment for CCSVI shows promise in improving physical- and mental health-related quality of life in individuals with multiple sclerosis. The study found significant short-term improvements in over 75% of those with relapsing remitting and primary progressive forms of MS.
A study presented at the Society of Interventional Radiology's annual meeting found that angioplasty can provide symptom relief for MS patients with venous obstructions. The procedure showed significant safety findings and provided symptomatic benefit in 55% of individuals treated.
Patients with relapsing onset MS who consumed alcohol, wine, coffee and fish took four to seven years longer to reach a walking aid than those who did not consume these items. In contrast, patients with progressive onset MS showed no significant differences in disease progression rates based on lifestyle factors.
A Kessler Foundation study found that people with multiple sclerosis perform poorly in memory and processing speed tests on hotter days. The research suggests a link between outdoor temperature and cognitive performance, which could impact clinical trials and treatment decisions.
Research found that women who had two or more pregnancies had a significantly reduced risk of developing MS symptoms, while men showed no association between children and MS risk. This study suggests a possible link between delayed motherhood and increased MS cases in women.
Helen Genova, a researcher at Kessler Foundation, has received the Women of Excellence Award in Health Sciences for her groundbreaking studies on cognitive fatigue in individuals with multiple sclerosis. Her innovative approach using functional MRI aims to develop more effective strategies for maintaining cognition and quality of life.
Academics at the University of Nottingham are recruiting patients with relapsing remitting multiple sclerosis to test the effect of a low dose of the helminth parasite Necator americanus on their immune system. The study aims to prove that hookworms can reduce MS symptoms and prevent relapses.
Researchers refuted the neurodegenerative hypothesis, which suggested myelin damage occurred without an immune system attack. The study found that immune defense played a role in triggering MS-like autoimmune disease.
A study published in Radiology found that computer-assisted cognitive rehabilitation improved attention and information processing skills in patients with relapsing-remitting multiple sclerosis. The rehabilitation program showed modifications in brain activity correlated with cognitive improvement, without structural changes in the brain.
Dr. Richard Ransohoff receives the 2012 John Dystel Prize for his groundbreaking work on understanding and treating multiple sclerosis. His research has led to a deeper understanding of MS progression and the development of novel therapeutic targets.
Scientists at the University of Nottingham discovered a new mechanism that explains how infections can trigger multiple sclerosis relapses. Regulatory T cells, which regulate immune responses, become less inhibitory when stimulated by bacterial or viral molecules, leading to increased inflammation.
Researchers have created a high-resolution virtual image of S1P1 receptors, critical in controlling MS and other diseases. The molecular map points toward promising new drug discovery paths.
A Wayne State University researcher is developing a model to focus on the causes of everyday MS symptoms. The goal is to provide more effective treatments and improve daily functioning for patients.
Researchers at Caltech have developed a gene therapy that stimulates the production of new oligodendrocytes from stem cells, enabling the brain to replace damaged myelin sheaths in demyelinating diseases like MS. The therapy uses leukemia inhibitory factor (LIF) to promote remyelination and reduce inflammation.
A recent study published in Neurology found that men are at higher risk of experiencing mild cognitive impairment (MCI) than women. The study, which analyzed data from 1,450 participants aged 70-89, revealed that the number of new cases of MCI per year was higher in men, affecting 72 per 1,000 people.
A new study by Kessler Foundation found that memory retraining using the modified Story Memory Technique (mSMT) increases cerebral activation in patients with multiple sclerosis. This suggests that behavioral interventions can positively affect brain function in MS, validating the clinical utility of cognitive rehabilitation.
A study published in Cell Stem Cell found that defects in myelin sheath regeneration surrounding nerves can be at least partially corrected following exposure to young immune cells. This suggests that regenerative therapies may work throughout the duration of MS, regardless of age. The findings provide new hope for treating this disease.
A study published in Cell Stem Cell highlights the possibility of reversing ageing in the central nervous system for multiple sclerosis (MS) patients. The age-associated decline of remyelination, a regenerative process, can be reversed using inflammatory cells from young mice.
Researchers have discovered a new mouse model for Multiple Sclerosis, using diabetic mice to replicate the disease's relapsing and remitting symptoms. This breakthrough may lead to the development of more effective treatments that turn temporary recovery into permanent repair.
A recent study published in Neurology reveals a sophisticated link between the Epstein-Barr virus (EBV) and multiple sclerosis (MS), potentially leading to new treatments and prevention strategies. Researchers found that EBV triggers inflammation and nerve cell damage in the brain, which is known to cause MS symptoms.
Researchers at UTHealth found evidence that multiple sclerosis affects the thalamus, a brain region controlling cognitive function, sensory processing, and motor skills. The study used MRI scans to compare patients with MS to healthy controls, revealing volume loss in the thalamus related to disease severity.
Multiple sclerosis may not be an autoimmune disease, but rather a metabolic disorder. This new framework could help guide researchers toward new treatments and ultimately a cure for the disease. The lipid hypothesis proposes that MS is caused by disruption of lipid homeostasis in the central nervous system.
Researchers at the University of Alberta have discovered a new way to track the progression of multiple sclerosis by using powerful MRI to measure iron levels in brain tissue. The study found that high iron levels are associated with physical disabilities and may be an early marker of MS.
A new study published in the New England Journal of Medicine found that multiple sclerosis begins in the cerebral cortex, contrary to previous theories. The research involved analyzing 563 brain biopsies and revealed distinct differences in lesions, providing clues for better disease management.
A new collaborative study from the Mayo Clinic and Cleveland Clinic suggests that multiple sclerosis may progress from the outermost layers of the brain to its deep parts. The researchers found that the cortex is involved early in MS and may even be the initial target of disease.
A study published in the American Journal of Pathology suggests laquinimod targets immune cells to increase neuroprotection in multiple sclerosis patients. The treatment increases brain-derived neurotrophic factor (BDNF) levels, contributing to neuron repair and limiting brain damage.
Neuromyelitis optica (NMO) is an inflammatory autoimmune disease that damages optic nerves and spinal cord. Mayo Clinic researchers have identified critical steps leading to myelin destruction, which could lead to better diagnosis and treatment of the disease.
A University at Buffalo study of 252 volunteers identified an association between chronic cerebrospinal venous insufficiency (CCSVI) and multiple sclerosis (MS) risk factors, including infectious mononucleosis, irritable bowel syndrome, and smoking. The findings suggest that CCSVI may be a vascular condition similar to MS, warranting f...
A modified Story Memory Technique was found to be effective in improving learning and memory deficits in people with multiple sclerosis. The treatment group showed greater activation in a widespread cortical network, indicating improved cognitive function.
Two Kessler Foundation researchers received over $100,000 in National Multiple Sclerosis Society grants to investigate cognitive impairments in MS. The studies aim to improve processing speed and understand the relationship between white matter damage and cognitive decline.
Researchers have discovered that connexin 36 protects mouse pancreatic beta-cells against immune molecules prevalent in type 1 diabetes. Additionally, a study found that PTHrP drives breast tumor initiation, progression, and metastasis in mice, suggesting it as a potential therapy target.
Researchers discovered that crocin in saffron exerts protective effects on brain cells and prevented damage in models of MS. The study also found a link between an ancient virus and cell stress leading to inflammation in the disease.
The study found that Ocrelizumab led to a 89% reduction in brain lesions and reduced the number of new multiple sclerosis attacks over 24 weeks. This suggests targeting B cells could help treat MS.
Research suggests that natural intestinal flora may play a crucial role in the emergence of multiple sclerosis. Beneficial bacteria can activate immune cells and trigger an overreaction of the immune system in genetically predisposed individuals. This finding has important implications for disease prevention and treatment.
Scientists have developed a sensor array that can diagnose multiple sclerosis from exhaled breath, offering a fast, inexpensive and non-invasive alternative to traditional methods. The technology has been tested in humans and shows promising results, rivaling the accuracy of spinal taps without pain or risk.
A potential new drug target has been discovered to stop debilitating effects of MS by preventing brain cell death caused by granzyme B. The target is the M6PR receptor, which allows granzyme B to enter neurons and wreak havoc.
A six-month randomized controlled trial found no added benefit from high-dose vitamin D over and above ongoing low-dose vitamin D supplementation in treating relapsing-remitting multiple sclerosis. The study involved 23 participants with MS, who received either high-dose or placebo high-dose vitamin D, and showed no significant differe...
Research suggests that shift work in teenagers may increase the risk of developing multiple sclerosis, a central nervous system autoimmune inflammatory disorder. Disruption of the circadian rhythm and sleep patterns are believed to contribute to this increased risk.
A team from the University of Utah has received a $275,000 NIH grant to study brain tissue from patients with primary progressive multiple sclerosis (PPMS) using advanced technology called deep sequencing. The goal is to identify viruses that might play a role in the development of PPMS and potentially lead to new treatments.
A new oral drug, teriflunomide, has been shown to significantly reduce the relapse rate of people with multiple sclerosis and slow the progression of the disease. The drug was found to be effective in increasing the time between relapses and reducing disease progression by almost 30%.
A systematic review found that taking natalizumab for two years lowers the number of MS patients who experience relapses and progression of disability. The medication also delays disease progression, according to MRI brain scans.
A meta-analysis found a strong association between CCSVI and multiple sclerosis, but the low quality of included studies prevents a definitive conclusion. The variation in study results suggests that factors such as sample size, ultrasound techniques, and training of operators may contribute to the heterogeneity.
A review of eight studies found an association between chronic cerebrospinal venous insufficiency and multiple sclerosis, but poor study quality and inconsistencies hinder definitive conclusions. Further research is needed to clarify the relationship.
A glucosamine-like dietary supplement, N-acetylglucosamine (GlcNAc), suppresses multiple sclerosis attacks by inhibiting abnormal T-cell growth and function. The study, published in The Journal of Biological Chemistry, suggests a novel mechanism for affecting T-cell function and autoimmunity.
Researchers at University of California - San Diego have discovered that inhibiting a single enzyme helps slow disease progression in a mouse model of multiple sclerosis. The study suggests that targeting fatty acid metabolism could lead to new therapies with fewer side effects.
Researchers at Cleveland institutions collaborate on a ground-breaking study testing the feasibility and safety of using mesenchymal stem cells to treat multiple sclerosis. The Phase 1 trial aims to decrease disease activity and promote repair in patients with MS.
Researchers identified 29 new genetic variants linked to multiple sclerosis, shedding light on immunological pathways and immune system involvement. The study confirms 23 known genetic associations and provides insight into a possible link between genetic and environmental risk factors.
An international team of scientists identified 29 new genetic variants linked to multiple sclerosis, providing key insights into the biology of the disease. The study confirms 23 previously known genetic associations and doubles the number of genes associated with MS.